ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
163 hedge funds and large institutions have $1.17B invested in Acorda Therapeutics in 2013 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 64 increasing their positions, 47 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
17% less capital invested
Capital invested by funds: $1.4B → $1.17B (-$231M)
Holders
163
Holding in Top 10
2
Calls
$1.22M
Puts
$984K
Top Buyers
| 1 | +$19.8M | |
| 2 | +$15M | |
| 3 | +$10.7M | |
| 4 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
+$7.37M |
| 5 |
Renaissance Technologies
New York
|
+$7.31M |
Top Sellers
| 1 | -$59.4M | |
| 2 | -$23.4M | |
| 3 | -$14M | |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$11.8M |
| 5 |
AG
Artal Group
Luxembourg
|
-$11.5M |